A new prescription drug monitoring program is going into effect that will impact many health care institutions and professionals. Effective October 2, 2018, as a result of the implementation of California Senate Bill 482, practitioners must, with limited exception, review the prescription history of their patients no more than 24 hours prior to prescribing a Schedule II, III, or IV drug for the first time and at least every four months thereafter.
View entire article here.
In an increasingly globalized world, it is extremely important to understand what is involved in enforcing judgments against foreign assets. Given that there is no global system for enforcing a judgme
This is a phrase most litigators have heard, or perhaps said themselves, more than once. This phrase is intended to provoke a reactionary response in your opponent and demonstrate to them, and your cl
On December 22, 2021, the Austrian Data Protection Authority (DSB) found that medical news company, NetDoktor, violated Europe’s General Data Protection Regulation (GDPR) by using Google LLC’s popular
